ConductScience.org, home

Paper1427770

Molecular genotyping of N-acetylation polymorphism to predict phenotype.

Mashimo M and 3 others. Hum Genet, 1992. Cited by 63 papers, by iCite.

Cite this record

ConductScience Library. Molecular genotyping of N-acetylation polymorphism to predict phenotype. Papers, record 1427770. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1427770

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Molecular genotyping of N-acetylation polymorphism to predict phenotype.
PubMed
Journal
Hum Genet
PubMed
Year
1992
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
63
iCite
Relative citation ratio, by iCite
2.68
iCite
Revised in PubMed
2022-12-07
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mashimo MM
2Suzuki TT
3Abe MM
4Deguchi TT

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Arylamine N-AcetyltransferaseMajor topic
Asian PeopleMajor topic
IsoniazidMajor topic
Acetylation
Adult
Alleles
Biotransformation
Blotting, Southern
Chromatography, High Pressure Liquid
Female
Genotype
Humans
Japan
Male
Middle Aged
Phenotype
Polymorphism, Genetic
Predictive Value of Tests

Source PubMed

Download CSV of topics

References14

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12048215Polymorphism in human N-acetyltransferase--the case of the missing allele.Trends Pharmacol Sci1991https://conductscience.org/library/papers/2048215PubMed
21676262Structure and restriction fragment length polymorphism of genes for human liver arylamine N-acetyltransferases.Biochem Biophys Res Commun1991https://conductscience.org/library/papers/1676262PubMed
32664821N-acetyltransferase.Pharmacol Ther1989https://conductscience.org/library/papers/2664821PubMed
46849760A method to prevent the loss of isoniazid and acetylisoniazid in human plasma.Br J Clin Pharmacol1983https://conductscience.org/library/papers/6849760PubMed
56643626High-performance liquid chromatographic analysis of isoniazid and acetylisoniazid in biological fluids.J Chromatogr1983https://conductscience.org/library/papers/6643626PubMed
61675794Molecular mechanism of slow acetylation of drugs and carcinogens in humans.Proc Natl Acad Sci U S A1991https://conductscience.org/library/papers/1675794PubMed
73657568Isolation of genomic DNA.Methods Enzymol1987https://conductscience.org/library/papers/3657568PubMed
81968463Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases from human liver.J Biol Chem1990https://conductscience.org/library/papers/1968463PubMed
913918409Genetical and geographic studies on isoniazid inactivation.Science1961https://conductscience.org/library/papers/13918409PubMed
102340091Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression.DNA Cell Biol1990https://conductscience.org/library/papers/2340091PubMed
112376572Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver.J Biol Chem1990https://conductscience.org/library/papers/2376572PubMed
122860675N-acetylation pharmacogenetics.Pharmacol Rev1985https://conductscience.org/library/papers/2860675PubMed
132068113Diverse point mutations in the human gene for polymorphic N-acetyltransferase.Proc Natl Acad Sci U S A1991https://conductscience.org/library/papers/2068113PubMed
147320150Hydrophilic ion-pair reversed-phase high-performance liquid chromatography for the simultaneous assay of isoniazid and acetylisoniazid in serum: a microscale procedure.J Chromatogr1981https://conductscience.org/library/papers/7320150PubMed

Download CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.

PMIDTitleJournalYearIn PapersSource
42306253Acetylator status-guided rapid reintroduction of isoniazid in tuberculosis patients with drug-induced hepatotoxicity.J Clin Tuberc Other Mycobact Dis2026https://conductscience.org/library/papers/42306253PubMed
31964788N-Acetyltransferase 2 Genotypes among Zulu-Speaking South Africans and Isoniazid and N-Acetyl-Isoniazid Pharmacokinetics during Antituberculosis Treatment.Antimicrob Agents Chemother2020https://conductscience.org/library/papers/31964788PubMed
28959610Prevention of isoniazid toxicity by NAT2 genotyping in Senegalese tuberculosis patients.Toxicol Rep2016https://conductscience.org/library/papers/28959610PubMed
28870161Chronic dialysis, NAT2 polymorphisms, and the risk of isoniazid-induced encephalopathy - case report and literature review.BMC Nephrol2017https://conductscience.org/library/papers/28870161PubMed
23150149
NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: a randomized controlled trial for pharmacogenetics-based therapy.
Eur J Clin Pharmacol2013https://conductscience.org/library/papers/23150149PubMed
16570187The influence of various genotypes on the metabolic activity of NAT2 in a Chinese population.Eur J Clin Pharmacol2006https://conductscience.org/library/papers/16570187PubMed
15316701Arylamine N-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals.Eur J Clin Pharmacol2004https://conductscience.org/library/papers/15316701PubMed
15032315N-acetyltransferase 2 genotype-related efficacy of sulfasalazine in patients with rheumatoid arthritis.Pharm Res2004https://conductscience.org/library/papers/15032315PubMed
10229705Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer.Environ Health Perspect1999https://conductscience.org/library/papers/10229705PubMed
9618736Genotyping of the arylamine N-acetyltransferase polymorphism in the prediction of idiosyncratic reactions to trimethoprim-sulfamethoxazole in infants.Pharm World Sci1998https://conductscience.org/library/papers/9618736PubMed
9255559Acetylation as an indicator of risk.Environ Health Perspect1997https://conductscience.org/library/papers/9255559PubMed
7668286Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity.Am J Hum Genet1995https://conductscience.org/library/papers/7668286PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1427770

GET https://conductscience.org/api/papers/v1/1427770/authors